Pfizer PFE Derivative Liability
Derivative Liability at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:DerivativeLiabilities.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's derivative liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's derivative liability?
- Pfizer (PFE) reported derivative liability of $1.37B in Q1 2026.
- How has Pfizer's derivative liability changed year-over-year?
- Pfizer's derivative liability increased by 3.9% year-over-year, from $1.31B to $1.37B.
- What is the long-term trend for Pfizer's derivative liability?
- Over 5 years (2020 to 2025), Pfizer's derivative liability has grown at a 5.8% compound annual growth rate (CAGR), from $1.1B to $1.46B.